Lubiprostone is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. It was initially approved by the U.S. Food and Drug Administration (FDA) in 2006 and recommended for use in the by the ...
Learn more about AMITIZA and its associated conditions. See patient stories and explore support and savings options available to you. See Important Safety Information.
Find patient medical information for Lubiprostone Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Jul 15, 2017 ... Lubiprostone: learn about side effects, dosage, special precautions, and more on MedlinePlus.
Easy to read patient leaflet for Lubiprostone. Includes indications, proper use, special instructions, precautions, and possible side effects.
Read about Amitiza (lubiprostone) drug/medication treatment for constipation and irritable bowel syndrome (IBS) in women.
Lubiprostone drug substance occurs as white, odorless crystals or crystalline powder, is very soluble in ether and ethanol, and is practically insoluble in hexane and water. Amitiza is available as an imprinted, oval, soft gelatin capsule in two strengths. Pink capsules contain 8 mcg of lubiprostone and the following inactive ...
Chronic constipation is highly prevalent, reduces patients' quality of life, and imposes a significant health care burden on society. Lifestyle modifications and over-the-counter agents improve symptoms of constipation in some patients, however many patients have persistent symptoms and require the use of prescription ...
Pictures of Amitiza (Lubiprostone), drug imprint information, side effects for the patient.